Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianing Huang

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Nanobiotechnology|September 13, 2024
A nanobody-guided multifunctional T cell engager promotes strong anti-tumor responses via synergistic immuno-photothermal effectsShenxia Xie, Wei Shi, Siliang Duan, et al.
Cells|November 11, 2022
Screening, Expression, and Identification of Nanobody against SARS-CoV-2 Spike ProteinQianling Su, Wei Shi, Xianing Huang, et al.
Journal of Hematology & Oncology|November 30, 2023
Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppressionZiqiang Ding, Shuyang Sun, Xuan Wang, et al.
Theranostics|March 30, 2016
Folate-modified Chitosan Nanoparticles Containing the IP-10 Gene Enhance Melanoma-specific Cytotoxic CD8(+)CD28(+) T Lymphocyte ResponsesJian He, Siliang Duan, Xia Yu, et al.
Journal of Hematology & Oncology|July 3, 2026
Dual-modular-nanobody CAR-T cell technical platform against the solid tumor microenvironmentYangzi Li, Xuan Wang, Shangkun Zhang, et al.
Theranostics|September 29, 2023
A dendritic/tumor fusion cell vaccine enhances efficacy of nanobody-based CAR-T cells against solid tumorShuyang Sun, Ziqiang Ding, Li Gao, et al.
Journal of Biomedical Nanotechnology|June 16, 2016
Folate-Modified Chitosan Nanoparticles Coated Interferon-Inducible Protein-10 Gene Enhance Cytotoxic T Lymphocytes' Responses to Hepatocellular CarcinomaSiliang Duan, Mongkhoune Song, Jian He, et al.
Journal of Biomedical Nanotechnology|January 26, 2018
A Smart Detection System Based on Specific Magnetic and Rolling Cycle Amplification Signal-Amplified Dual-Aptamers to Accurately Monitor Minimal Residual Diseases in Patients with T-ALLXa Li, Bo Zhou, Zilong Zhao, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Nanobiotechnology|September 13, 2024
A nanobody-guided multifunctional T cell engager promotes strong anti-tumor responses via synergistic immuno-photothermal effectsShenxia Xie, Wei Shi, Siliang Duan, et al.
Cells|November 11, 2022
Screening, Expression, and Identification of Nanobody against SARS-CoV-2 Spike ProteinQianling Su, Wei Shi, Xianing Huang, et al.
Journal of Hematology & Oncology|November 30, 2023
Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppressionZiqiang Ding, Shuyang Sun, Xuan Wang, et al.
Theranostics|March 30, 2016
Folate-modified Chitosan Nanoparticles Containing the IP-10 Gene Enhance Melanoma-specific Cytotoxic CD8(+)CD28(+) T Lymphocyte ResponsesJian He, Siliang Duan, Xia Yu, et al.
Journal of Hematology & Oncology|July 3, 2026
Dual-modular-nanobody CAR-T cell technical platform against the solid tumor microenvironmentYangzi Li, Xuan Wang, Shangkun Zhang, et al.
Theranostics|September 29, 2023
A dendritic/tumor fusion cell vaccine enhances efficacy of nanobody-based CAR-T cells against solid tumorShuyang Sun, Ziqiang Ding, Li Gao, et al.
Journal of Biomedical Nanotechnology|June 16, 2016
Folate-Modified Chitosan Nanoparticles Coated Interferon-Inducible Protein-10 Gene Enhance Cytotoxic T Lymphocytes' Responses to Hepatocellular CarcinomaSiliang Duan, Mongkhoune Song, Jian He, et al.
Journal of Biomedical Nanotechnology|January 26, 2018
A Smart Detection System Based on Specific Magnetic and Rolling Cycle Amplification Signal-Amplified Dual-Aptamers to Accurately Monitor Minimal Residual Diseases in Patients with T-ALLXa Li, Bo Zhou, Zilong Zhao, et al.
Pageof 2